[Summary] Developing innovative drugs to improve human health
Shanghai Hengrui R&D Center was established in May 2004, located at No. 279 Wenjing Road, with a total investment of 200 million yuan, covering an area of 44,000 square meters, with a building area of 26,409.6 square meters, of which the production and testing workshop covers 10,005.6 square meters and the R&D center covers 10,053.53 square meters. It is one of the main R&D bases of Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Shanghai R&D Center is committed to the discovery of innovative drugs, focusing on anti-tumor, endocrine, cardiovascular, central nervous system, and macromolecular biology, covering the entire process of new drug development.
Currently, it undertakes several projects of the National Major New Drug Creation Technology Major Project. It has submitted 46 national patent applications and 33 PCT applications, and has begun to enter 16 countries including the United States, Europe, and Japan. Four innovative class I drugs have received approval for phase I clinical trials in China.
What does Shanghai Hengrui Pharmaceuticals Co., Ltd. require? Who is Shanghai Hengrui Pharmaceuticals Co., Ltd. hiring? recruitment: 销售类占比最多占39.5%，其次是医疗卫生/美容保健类占38.2%. What education can get in at ? 本科占比最多占52.6%，其次是硕士占28.9%. High education required at ? 硕士占28.9%，博士占11.8%. Work experience required at ? 不限占比最多占44.7%，其次是3-5年占28.9%. Where are the job locations at ? 上海占比最多占68.4%，其次是北京占5.3%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
